HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Vaccination | Image credit: Prostock-studio - stock.adobe.com
HPV Vaccination Cost-Effective at Preventing Cervical Cancer in Patients With HIV

November 21st 2024

Women living with HIV can reduce their risk of cervical cancer using a human papillomavirus (HPV) vaccine that is both cost-effective and effective in preventing the virus.

HIV | Image credit: Corona Borealis - stock.adobe.com
New Data Provide Clearer Picture on Adherence to Lenacapavir

November 18th 2024

HIV | Image credit: RAJCREATIONZS - stock.adobe.com
BIC/FTC/TAF Effective at Virologic Suppression in HIV Presenting Late

November 15th 2024

Liver | Image credit: PIC4U - stock.adobe.com
Liver Steatosis, Fibrosis Highly Prevalent in People Living With HIV

November 12th 2024

Madalitso Juwayeyi
Empowering Young Women in the Fight Against HIV

November 8th 2024

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
November 21st 2024

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Reactions Are Mixed as Gilead Announces PrEP Donations, Early Launch of Generic
May 11th 2019

Reactions Are Mixed as Gilead Announces PrEP Donations, Early Launch of Generic

Jaime Rosenberg
HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic version of the pill will come to market a year early. However, some activists are skeptic.
Survey Finds Pharmacy Students Have High Awareness of PrEP but Gaps Remain
May 8th 2019

Survey Finds Pharmacy Students Have High Awareness of PrEP but Gaps Remain

Jaime Rosenberg
Researchers from the University of Buffalo surveyed pharmacist students, finding high awareness of pre-exposure prophylaxis (PrEP) and generally positive attitudes towards it. However, the survey also revelaed gaps in knowledge, highlighting the need for more education.
PARTNER2 Study: Viral Suppression of HIV Prevents Sexual Transmission Between Gay Men
May 3rd 2019

PARTNER2 Study: Viral Suppression of HIV Prevents Sexual Transmission Between Gay Men

Wallace Stephens
Findings from PARTNER2 show that HIV-positive individuals who were virally suppressed by antiretroviral therapy had no risk of transmitting the virus by having sex without condoms.
Dr Stella Safo on How Changing Financial Models Might Create Management Challenges for HIV
May 1st 2019

Dr Stella Safo on How Changing Financial Models Might Create Management Challenges for HIV

As we move away from a system of external development grants that help us maintain our HIV models to a system where our returns on investment support the work that we do, there’s a concern that there will be some slimming down of services that get patients in to our practice, explained Stella A. Safo, MD, assistant professor of Medicine at the Icahn School of Medicine at Mount Sinai.
What We're Reading: Limited Screen Time for Children; HIV Prevention Drug Licensing; NYC Confirms 30 New Measles Cases
April 25th 2019

What We're Reading: Limited Screen Time for Children; HIV Prevention Drug Licensing; NYC Confirms 30 New Measles Cases

AJMC Staff
The World Health Organization recommends little to no screen time for children under age 5; senators urge HHS to ensure that government patents on the HIV prevention drug Truvada are properly licensed; New York City health officials have confirmed 31 new cases of measles in less than a week.
PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV
April 23rd 2019

PrEP May Offer Psychological Benefits to Gay, Bisexual Men at Risk for HIV

Jaime Rosenberg
A new study has identified lower rates of sexual anxiety among gay and bisexual men taking pre-exposure prophylaxis (PrEP).
Antibody May Suppress HIV for Up to 4 Months in Patients Halting ART Regimens
April 22nd 2019

Antibody May Suppress HIV for Up to 4 Months in Patients Halting ART Regimens

Jaime Rosenberg
In a study of 29 virally suppressed patients who discontinued antiretroviral therapy (ART), every patient was able to maintain viral suppression from infusions of an antibody that blocks the HIV-binding site on CD4+ T cells.
In Small Amount of Patients, CD4+ T Cells Continue to Decline Despite Being Virally Suppressed
April 19th 2019

In Small Amount of Patients, CD4+ T Cells Continue to Decline Despite Being Virally Suppressed

Jaime Rosenberg
In rare cases, despite being on antiretroviral therapy and being virally suppressed, patients experience extreme immune decline.
Is Immunotherapy the Key to Developing an HIV Vaccine?
April 18th 2019

Is Immunotherapy the Key to Developing an HIV Vaccine?

Wallace Stephens
A new immunotherapy approach was found to both expose HIV concealed within CD4+ T cells and kill it, which could potentially lead to an eventual vaccine for the virus.
What We're Reading: Doctors Charged in Opioid Scheme; First US CRISPR Treatment; "Bubble Boy" Disease Cured
April 18th 2019

What We're Reading: Doctors Charged in Opioid Scheme; First US CRISPR Treatment; "Bubble Boy" Disease Cured

AJMC Staff
Dozens of doctors and other medical professionals have been charged with exchanging opioids and other drugs for sex and cash; the first 2 patients in the United States have been treated with CRISPR; doctors have cured infants of immunodeficiency syndrome using gene therapy made from HIV.
Depressive Symptoms May Increase the Risk of Death in Patients With HIV
April 13th 2019

Depressive Symptoms May Increase the Risk of Death in Patients With HIV

Wallace Stephens
Prevalence of depressive symptoms among individuals with HIV may lead to an increased risk of mortality.
What We're Reading: New Medicare for All Bill; Medicaid Work Requirement Appeal; PrEP Royalties
April 11th 2019

What We're Reading: New Medicare for All Bill; Medicaid Work Requirement Appeal; PrEP Royalties

AJMC Staff
Senator Bernie Sanders, I-Vermont, has reintroduced a Medicare for All bill while other Democrats eye an alternative; the Trump administration is appealing a federal judge's decision to toss out Medicaid work requirements in Kentucky and Arkansas; AIDS activists are pushing CDC to force Gilead to give the agency royalties for Truvada.
PrEP Initiation Associated With Increased STI Incidence Among Gay, Bisexual Men
April 11th 2019

PrEP Initiation Associated With Increased STI Incidence Among Gay, Bisexual Men

Jaime Rosenberg
A study of gay and bisexual men found that incidence of sexually transmitted infections (STIs) increased following pre-exposure prophylaxis (PrEP) initiation.
Can Couple-Based Interventions Prevent the Spread of HIV?
April 5th 2019

Can Couple-Based Interventions Prevent the Spread of HIV?

Wallace Stephens
Researchers evaluated differences in effectiveness of 2 couple-based preventive interventions aimed to reduce the spread of HIV and sexually transmitted infections among individuals in community supervision programs.
Weighing Management Strategies for HIV Medication Safety, Cost
April 4th 2019

Weighing Management Strategies for HIV Medication Safety, Cost

Jaime Rosenberg
While medical advances have improved lifespan and quality of life for patients with HIV, there are still opportunities for strategies that address both medication safety and costs.
Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV
March 30th 2019

Dr Ian Frank on the Convenience, Benefits of Single-Tablet Regimens for HIV

People living with HIV who are taking single-tablet regimens have better medication adherence and lower hospitalizations than those taking multi-tablet regimens, explained Ian Frank, MD, professor of medicine, Perelman School of Medicine, University of Pennsylvania,
5 Findings From the AMCP Managed Care & Specialty Pharmacy Annual Meeting
March 29th 2019

5 Findings From the AMCP Managed Care & Specialty Pharmacy Annual Meeting

Jaime Rosenberg
During the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmcy Annual Meeting, held March 25-28, in San Diego, California, managed care professionals from across the globe gathered to discuss opportunities and challenges facing stakeholders in pharmaceutical management, ranging from drug pricing reform to strategies to address the opioid epidemic.
What We're Reading: New Healthcare Giant; Monsanto Lawsuit; Organ Transplants From Donor with HIV
March 28th 2019

What We're Reading: New Healthcare Giant; Monsanto Lawsuit; Organ Transplants From Donor with HIV

AJMC Staff
Insurer Centene strikes a deal to acquire WellCare, creating a new giant in the healthcare market; a federal jury orders Monsanto to pay over $80 million to a plaintiff whose cancer was found to be caused by a common weed killer; surgeons perform a transplant using a kidney from a living donor with HIV.
Can Staggered Care Save Money While Achieving Viral Suppression in Youth With HIV?
March 27th 2019

Can Staggered Care Save Money While Achieving Viral Suppression in Youth With HIV?

Wallace Stephens
In an ongoing study, researchers seek to determine whether a staggered, "step up" intervention model could be more successful and cost-effective than standard care for achieving viral suppression in youths living with HIV.
Recommendations Discuss When Patients on ART Can Consider ATI
March 23rd 2019

Recommendations Discuss When Patients on ART Can Consider ATI

Allison Inserro
Recently published consensus recommendations discuss analytical antiretroviral treatment interruption (ATI), including who can be included and excluded and when to restart antiretroviral therapy (ART).
This Week in Managed Care: March 22, 2019
March 22nd 2019

This Week in Managed Care: March 22, 2019

This week, the top managed care news included new primary prevention guidelines that could increase the use of some diabetes drugs; the FDA expanded criteria for which patients can take part in clinical trials; a summit on value-based insurance design showed the need for tough conversations with stakeholders.
CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection
March 20th 2019

CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection

Wallace Stephens
The majority of new HIV infections have been found to be transmitted by individuals who are unaware that they have HIV or by those who know they have HIV but are not receiving treatment to suppress their infection.
Participation in Community Groups Found to Increase Awareness of PrEP
March 16th 2019

Participation in Community Groups Found to Increase Awareness of PrEP

Wallace Stephens
Gay or bisexual men who participated in community groups were found have a higher awareness of pre-exposure prophylaxis (PrEP) than those who did not. PrEP has proven to be a successful preventive measure to decrease the spread of HIV.
Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding
March 12th 2019

Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding

Jaime Rosenberg Allison Inserro
The president has released his budget for fiscal year (FY) 2020, which calls for converting Medicaid to a system of block grants and requiring all able-bodied Medicaid recipients to hold a job or perform community service. The $87.1 billion allocated to HHS, a 12% cut, would include increases to federal HIV funding, but drops in global funding, as well as cuts to the National Institutes of Health (NIH).
Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV
March 9th 2019

Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV

Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard University.
This Week in Managed Care: March 8, 2019
March 8th 2019

This Week in Managed Care: March 8, 2019

This week, the top managed care news included Scott Gottlieb, MD, resigning as FDA commissioner; Eli Lilly offering a discounted version of Humalog; and a second patient reported cured of HIV.
Is There a Future for Effective Vaccines for Infectious Diseases?
March 8th 2019

Is There a Future for Effective Vaccines for Infectious Diseases?

Jaime Rosenberg
This is part 1 of a 3-part vaccine series covering the potential of vaccines for infectious diseases, the impact of the antivaccination movement, and the promise of vaccines for cancer treatment.
What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee
March 5th 2019

What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee

AJMC Staff
A second patient has been reported to have been cured of infection with HIV since the start of the epidemic; thousands have reported complications to the FDA with medical devices and implants; a 30-person national ethics committee has been appointed in China to oversee high-risk clinical trials.
Estimating the Cost-Effectiveness of PrEP Over 40 Years
March 2nd 2019

Estimating the Cost-Effectiveness of PrEP Over 40 Years

Wallace Stephens
Short-term investments pertaining to the distribution of PrEP are expected to result in long-term cost-savings and promote significant health benefits following its introduction in Germany, according to a new modelling study.
HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid
February 28th 2019

HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid

Jaime Rosenberg
Between 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs accounted for more than 90% of spending on these antivirals.
<1
...
161718192021222324
...
30>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo